menu
    • menu

    Company profile for Aspect Biosystems

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue t...
    Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aspect BiosystemsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    1781 West 75th Ave Vancouver, BC V6P6P2
    Telephone
    Telephone
    +1 604 263 0502
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aspectbiosystems.com/
    Linkedin
    Linkedin
    https://ca.linkedin.com/company/aspect-biosystems
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Paris Packaging Week

    Paris Packaging Week

    Not Confirmed

    envelop Contact Supplier

    Paris Packaging Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novo Expands Diabetes Cell Therapy Partnership with Aspect Bio
    Novo Expands Diabetes Cell Therapy Partnership with Aspect Bio

    21 Jan 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-expands-diabetes-cell-therapy-partnership-with-aspect-biosystems-2026-01-20/

    REUTERS
    21 Jan 2026
    Share Share
    Aspect Biosystems, Novo Nordisk Advance Partnership For Diabetes
    Aspect Biosystems, Novo Nordisk Advance Partnership For Diabetes

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221733/0/en/Aspect-Biosystems-and-Novo-Nordisk-enter-new-phase-of-partnership-to-develop-curative-medicines-for-diabetes.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    Aspect Biosystems Presents Preclinical Data on Adrenal Tissue
    Aspect Biosystems Presents Preclinical Data on Adrenal Tissue

    14 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250714081536/en/Aspect-Biosystems-Presents-New-Preclinical-Data-on-Adrenal-Bioprinted-Tissue-Therapeutics-at-ENDO-2025

    BUSINESSWIRE
    14 Jul 2025
    Share Share
    Aspect Biosystems Raises 115M Series B To Advance Bioprinted Tissue
    Aspect Biosystems Raises 115M Series B To Advance Bioprinted Tissue

    08 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250108827523/en

    BUSINESSWIRE
    08 Jan 2025
    Share Share
    BIOTECanada Welcomes Three New Members to its Board of Directors
    BIOTECanada Welcomes Three New Members to its Board of Directors

    09 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241008164117/en

    BUSINESSWIRE
    09 Oct 2024
    Share Share
    Aspect wins $72.75m from Canadian government for bioprinted pipeline
    Aspect wins $72.75m from Canadian government for bioprinted pipeline

    11 Jul 2024

    // Jenna Philpott PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/aspect-wins-72-75m-from-canadian-government-for-bioprinted-pipeline/

    Jenna Philpott PHARMACEUTICAL-TECHNOLOGY
    11 Jul 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search